Anebulo Pharmaceuticals annual total assets
2021
2022
2023
2024
2025
Anebulo Pharmaceuticals Total Assets Growth & History (ANEB)
Anebulo Pharmaceuticals's total assets was $12.1M for fiscal 2025.
View full Anebulo Pharmaceuticals company overviewAnebulo Pharmaceuticals annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | $12.1M | $8.1M | +198.19% |
| 2024 | 2024-06-30 | $4.1M | −$7.6M | −65.10% |
| 2023 | 2023-06-30 | $11.7M | −$3.9M | −25.09% |
| 2022 | 2022-06-30 | $15.6M | −$6.1M | −28.05% |
| 2021 | 2021-06-30 | $21.7M | — | — |
Anebulo Pharmaceuticals quarterly total assets
As of Jun 30, 2020
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2025-12-31 | $9.4M | −$6.4M | −40.52% |
| Q1 2026 | 2025-09-30 | $10.7M | $8.2M | +333.60% |
| Q4 2025 | 2025-06-30 | $12.1M | $8.1M | +198.19% |
| Q3 2025 | 2025-03-31 | $14.0M | $8.0M | +133.64% |
| Q2 2025 | 2024-12-31 | $15.8M | $8.3M | +111.19% |
| Q1 2025 | 2024-09-30 | $2.5M | −$6.6M | −72.72% |
| Q4 2024 | 2024-06-30 | $4.1M | −$7.6M | −65.10% |
| Q3 2024 | 2024-03-31 | $6.0M | −$8.4M | −58.46% |
| Q2 2024 | 2023-12-31 | $7.5M | −$9.4M | −55.59% |
| Q1 2024 | 2023-09-30 | $9.0M | −$10.8M | −54.34% |
| Q4 2023 | 2023-06-30 | $11.7M | −$3.9M | −25.09% |
| Q3 2023 | 2023-03-31 | $14.4M | −$2.8M | −16.33% |
| Q2 2023 | 2022-12-31 | $16.9M | −$2.1M | −10.95% |
| Q1 2023 | 2022-09-30 | $19.8M | −$684,977 | −3.34% |
| Q4 2022 | 2022-06-30 | $15.6M | −$6.1M | −28.05% |
| Q3 2022 | 2022-03-31 | $17.2M | $13.0M | +301.92% |
| Q2 2022 | 2021-12-31 | $19.0M | — | — |
| Q1 2022 | 2021-09-30 | $20.5M | — | — |
| Q4 2021 | 2021-06-30 | $21.7M | $18.6M | +615.00% |
| Q3 2021 | 2021-03-31 | $4.3M | — | — |
| As of Jun 30, 2020 | 2020-06-30 | $3.0M | — | — |
Anebulo Pharmaceuticals total assets trends
Between the periods ended 2021-06-30 and 2025-06-30, Anebulo Pharmaceuticals's total assets decreased from $21.7M to $12.1M, a change of −$9.5M. The latest reported quarter, Q2 2026, shows $9.4M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Anebulo Pharmaceuticals source filings ↗